5.02 USD
+0.05 (+1.01%)
Overall NEPH gets a fundamental rating of 5 out of 10. We evaluated NEPH against 130 industry peers in the Machinery industry. While NEPH has a great health rating, its profitability is only average at the moment. While showing a medium growth rate, NEPH is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year NEPH was profitable.
In the past year NEPH had a positive cash flow from operations.
In the past 5 years NEPH reported 4 times negative net income.
In the past 5 years NEPH reported 4 times negative operating cash flow.
1.2 Ratios
NEPH has a Return On Assets of 11.18%. This is amongst the best in the industry. NEPH outperforms 81.54% of its industry peers.
Looking at the Return On Equity, with a value of 14.80%, NEPH is in the better half of the industry, outperforming 74.62% of the companies in the same industry.
NEPH's Return On Invested Capital of 11.15% is fine compared to the rest of the industry. NEPH outperforms 76.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.18% | ||
| ROE | 14.8% | ||
| ROIC | 11.15% |
ROA(3y)-26.57%
ROA(5y)-25.75%
ROE(3y)-50%
ROE(5y)-44.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 8.26%, NEPH is in the better half of the industry, outperforming 66.15% of the companies in the same industry.
NEPH has a Operating Margin of 8.06%. This is comparable to the rest of the industry: NEPH outperforms 50.00% of its industry peers.
NEPH has a Gross Margin of 63.24%. This is amongst the best in the industry. NEPH outperforms 98.46% of its industry peers.
In the last couple of years the Gross Margin of NEPH has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.06% | ||
| PM (TTM) | 8.26% | ||
| GM | 63.24% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.79%
GM growth 5Y0.91%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NEPH is creating some value.
Compared to 1 year ago, NEPH has about the same amount of shares outstanding.
Compared to 5 years ago, NEPH has more shares outstanding
The debt/assets ratio for NEPH is higher compared to a year ago.
2.2 Solvency
NEPH has an Altman-Z score of -2.80. This is a bad value and indicates that NEPH is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of NEPH (-2.80) is worse than 85.38% of its industry peers.
The Debt to FCF ratio of NEPH is 0.01, which is an excellent value as it means it would take NEPH, only 0.01 years of fcf income to pay off all of its debts.
NEPH's Debt to FCF ratio of 0.01 is amongst the best of the industry. NEPH outperforms 93.08% of its industry peers.
NEPH has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
NEPH has a better Debt to Equity ratio (0.00) than 85.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Altman-Z | -2.8 |
ROIC/WACC1.16
WACC9.64%
2.3 Liquidity
NEPH has a Current Ratio of 4.34. This indicates that NEPH is financially healthy and has no problem in meeting its short term obligations.
NEPH's Current ratio of 4.34 is amongst the best of the industry. NEPH outperforms 88.46% of its industry peers.
NEPH has a Quick Ratio of 3.23. This indicates that NEPH is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.23, NEPH belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.34 | ||
| Quick Ratio | 3.23 |
3. Growth
3.1 Past
NEPH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 244.44%, which is quite impressive.
NEPH shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.36%.
NEPH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.51% yearly.
EPS 1Y (TTM)244.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)32.36%
Revenue growth 3Y11.49%
Revenue growth 5Y6.51%
Sales Q2Q%35.42%
3.2 Future
NEPH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39523200.00% yearly.
The Revenue is expected to grow by 18.15% on average over the next years. This is quite good.
EPS Next Y3233944820422206000%
EPS Next 2Y20999820744.76%
EPS Next 3Y39523200%
EPS Next 5YN/A
Revenue Next Year33.54%
Revenue Next 2Y22.44%
Revenue Next 3Y18.15%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 38.62, the valuation of NEPH can be described as expensive.
NEPH's Price/Earnings ratio is a bit more expensive when compared to the industry. NEPH is more expensive than 64.62% of the companies in the same industry.
NEPH is valuated rather expensively when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 32.81 indicates a quite expensive valuation of NEPH.
Based on the Price/Forward Earnings ratio, NEPH is valued a bit more expensive than the industry average as 65.38% of the companies are valued more cheaply.
NEPH is valuated rather expensively when we compare the Price/Forward Earnings ratio to 23.78, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.62 | ||
| Fwd PE | 32.81 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NEPH indicates a slightly more expensive valuation: NEPH is more expensive than 73.08% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NEPH indicates a somewhat cheap valuation: NEPH is cheaper than 70.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.63 | ||
| EV/EBITDA | 30.38 |
4.3 Compensation for Growth
NEPH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NEPH's earnings are expected to grow with 39523200.00% in the coming years.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y20999820744.76%
EPS Next 3Y39523200%
5. Dividend
5.1 Amount
No dividends for NEPH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:NEPH (12/12/2025, 8:00:01 PM)
5.02
+0.05 (+1.01%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners47.19%
Inst Owner Change3.35%
Ins Owners10.85%
Ins Owner Change0.7%
Market Cap53.36M
Revenue(TTM)17.93M
Net Income(TTM)1.48M
Analysts82.5
Price Target7.14 (42.23%)
Short Float %0.07%
Short Ratio0.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)212.75%
Min EPS beat(2)178.43%
Max EPS beat(2)247.06%
EPS beat(4)4
Avg EPS beat(4)450.49%
Min EPS beat(4)178.43%
Max EPS beat(4)1080.39%
EPS beat(8)6
Avg EPS beat(8)227.45%
EPS beat(12)8
Avg EPS beat(12)151.69%
EPS beat(16)10
Avg EPS beat(16)98.99%
Revenue beat(2)2
Avg Revenue beat(2)19.73%
Min Revenue beat(2)18.66%
Max Revenue beat(2)20.79%
Revenue beat(4)4
Avg Revenue beat(4)19.17%
Min Revenue beat(4)6.29%
Max Revenue beat(4)30.93%
Revenue beat(8)4
Avg Revenue beat(8)4.24%
Revenue beat(12)6
Avg Revenue beat(12)3.61%
Revenue beat(16)7
Avg Revenue beat(16)0.06%
PT rev (1m)27.27%
PT rev (3m)27.27%
EPS NQ rev (1m)200%
EPS NQ rev (3m)200%
EPS NY rev (1m)144.44%
EPS NY rev (3m)450%
Revenue NQ rev (1m)8.38%
Revenue NQ rev (3m)8.38%
Revenue NY rev (1m)7.19%
Revenue NY rev (3m)7.19%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.62 | ||
| Fwd PE | 32.81 | ||
| P/S | 2.98 | ||
| P/FCF | 19.63 | ||
| P/OCF | 19.63 | ||
| P/B | 5.33 | ||
| P/tB | 6.1 | ||
| EV/EBITDA | 30.38 |
EPS(TTM)0.13
EY2.59%
EPS(NY)0.15
Fwd EY3.05%
FCF(TTM)0.26
FCFY5.1%
OCF(TTM)0.26
OCFY5.1%
SpS1.69
BVpS0.94
TBVpS0.82
PEG (NY)0
PEG (5Y)N/A
Graham Number1.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.18% | ||
| ROE | 14.8% | ||
| ROCE | 13.4% | ||
| ROIC | 11.15% | ||
| ROICexc | 21.42% | ||
| ROICexgc | 27.63% | ||
| OM | 8.06% | ||
| PM (TTM) | 8.26% | ||
| GM | 63.24% | ||
| FCFM | 15.16% |
ROA(3y)-26.57%
ROA(5y)-25.75%
ROE(3y)-50%
ROE(5y)-44.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.79%
GM growth 5Y0.91%
F-Score7
Asset Turnover1.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 722.5 | ||
| Cash Conversion | 171.33% | ||
| Profit Quality | 183.59% | ||
| Current Ratio | 4.34 | ||
| Quick Ratio | 3.23 | ||
| Altman-Z | -2.8 |
F-Score7
WACC9.64%
ROIC/WACC1.16
Cap/Depr(3y)38.4%
Cap/Depr(5y)49.1%
Cap/Sales(3y)0.77%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)244.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y3233944820422206000%
EPS Next 2Y20999820744.76%
EPS Next 3Y39523200%
EPS Next 5YN/A
Revenue 1Y (TTM)32.36%
Revenue growth 3Y11.49%
Revenue growth 5Y6.51%
Sales Q2Q%35.42%
Revenue Next Year33.54%
Revenue Next 2Y22.44%
Revenue Next 3Y18.15%
Revenue Next 5YN/A
EBIT growth 1Y250.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y208.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y208.98%
OCF growth 3YN/A
OCF growth 5YN/A
NEPHROS INC / NEPH FAQ
What is the fundamental rating for NEPH stock?
ChartMill assigns a fundamental rating of 5 / 10 to NEPH.
What is the valuation status of NEPHROS INC (NEPH) stock?
ChartMill assigns a valuation rating of 3 / 10 to NEPHROS INC (NEPH). This can be considered as Overvalued.
Can you provide the profitability details for NEPHROS INC?
NEPHROS INC (NEPH) has a profitability rating of 4 / 10.
Can you provide the expected EPS growth for NEPH stock?
The Earnings per Share (EPS) of NEPHROS INC (NEPH) is expected to grow by 3233944820422206000% in the next year.